Richard Roths Media Announces $52 Million Dollar Investment Approval to Expand its AI-Driven Marketing Systems 
Four Inc. Secures Spot on Washington Technology’s Top 100 Government Contractors List for 11th Consecutive Year 
Tat Hong Equipment Service Co., Ltd. Announces 2025/26 Annual Results Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for the First Quarter 2023
― Appointed Alex C. Sapir CEO & President, effective July 1st, 2023 ― ― On…
uniQure Announces Sale of Royalty Interest in HEMGENIX® for Up To $400 Million
~ uniQure to receive $375 million upfront cash payment ~ ~ Under the existing agreement…
Avalo to Present at ATS 2023 Respiratory Innovation Summit
WAYNE, Pa. and ROCKVILLE, Md., May 15, 2023 (GLOBE NEWSWIRE) — Avalo Therapeutics, Inc. (Nasdaq:…
Orchard Therapeutics Reports First Quarter 2023 Financial Results and Announces Initiation of Rolling Submission for Biologics License Application of OTL-200 for Metachromatic Leukodystrophy to U.S. FDA
OTL-200 Biologics License Application (BLA) submission completion anticipated in mid-2023 Libmeldy revenue and commercial patients…
First Wave BioPharma CEO James Sapirstein to Present at 2023 BIO International Conference
BOCA RATON, Fla., May 15, 2023 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc. (NASDAQ: FWBI)…
Fulcrum Therapeutics Appoints Alex C. Sapir Chief Executive Officer
— Industry veteran brings more than 20 years of experience; will assume role effective July…
Trevena Reports First Quarter 2023 Results and Provides Business Update
OLINVYK receives regulatory approval in China, triggering $3 million milestone payment from Company’s China partner…
Zynerba Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Highlights
Enrollment continues in RECONNECT, a confirmatory pivotal Phase 3 trial of Zygel™ in patients with…
Disc Medicine Reports First Quarter 2023 Financial Results and Provides Business Update
Two ongoing Phase 2 studies of bitopertin in EPP; initial safety and efficacy data from…
Larimar Therapeutics Reports Preliminary Top-line Data from Phase 2 Trial’s 25 mg Cohort Showing Increases in Frataxin Levels in Patients with Friedreich’s Ataxia and First Quarter 2023 Financial Results
Safety data indicate that repeated subcutaneous injections of 25 mg CTI-1601 were generally well tolerated…
Oxford Biomedica launches TetraVecta – the next generation lentiviral vector system
Oxford Biomedica launches TetraVectaTM – the next generation lentiviral vector system Oxford, UK – 15…
Indigo Appoints Dr. Arun Venkatasubramanian as Chief Technology Officer
PRESS RELEASE Indigo Appoints Dr. Arun Venkatasubramanian as Chief Technology Officer Arun is an award-winning…
Akero Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
— Results from Cohort D, an expansion cohort of type 2 diabetic, pre-cirrhotic NASH patients…
Gracell Biotechnologies Reports First Quarter 2023 Unaudited Financial Results, and Provides Corporate Update
Presenting longer-term follow-up data from investigator-initiated trial (IIT) evaluating BCMA/CD19 dual-targeting FasTCAR-T GC012F in relapsed/refractory…
Genelux Corporation Announces $33 Million Private Placement
WESTLAKE VILLAGE, Calif., May 15, 2023 (GLOBE NEWSWIRE) — Genelux Corporation (NASDAQ: GNLX), a late clinical-stage…
ASLAN Pharmaceuticals Presents New Data on Eblasakimab and Farudodstat in Two Late-Breaking Presentations at the 1st International Societies for Investigative Dermatology Meeting
First study comparing blockade of the IL-4 receptor and IL-13 receptor, both components of the…
Castellum, Inc. Announces First Quarter Financial Results and Provides Forward Guidance
Castellum, Inc. Announces First Quarter Financial Results and Provides Forward Guidance Revenues for the three…
Novan Reports First Quarter 2023 Financial Results and Provides Corporate Update
– Continued progress toward PDUFA goal date of January 5, 2024, for berdazimer gel, 10.3%…
BiomX Reports First Quarter 2023 Financial Results and Provides Business Update
Announced Positive Results from Part 1 of Ongoing Phase 1b/2a Trial of BX004 for Treatment…
Chat GPT Integrated into BlueRush′s IndiVideo Platform
Integration with IndiVideo allows video assets to be created in minutes based on simple instructions…